vTv Therapeutics (VTVT) Operating Margin: 2014-2025
Historic Operating Margin for vTv Therapeutics (VTVT) over the last 10 years, with Sep 2025 value amounting to 213,980.00%.
- vTv Therapeutics' Operating Margin was N/A to 213,980.00% in Q3 2025 from the same period last year, while for Sep 2025 it was -2,966.67%, marking a year-over-year change of. This contributed to the annual value of -2,377.58% for FY2024, which is 2693506.00% up from last year.
- As of Q3 2025, vTv Therapeutics' Operating Margin stood at 213,980.00%, which was up 843.59% from -28,776.47% recorded in Q4 2024.
- vTv Therapeutics' Operating Margin's 5-year high stood at 400,000.00% during Q2 2023, with a 5-year trough of -123,433.33% in Q4 2021.
- In the last 3 years, vTv Therapeutics' Operating Margin had a median value of 67,242.86% in 2023 and averaged 111,236.67%.
- In the last 5 years, vTv Therapeutics' Operating Margin plummeted by 12,346,193bps in 2021 and then soared by 44,474,444bps in 2023.
- vTv Therapeutics' Operating Margin (Quarterly) stood at -123,433.33% in 2021, then skyrocketed by 5,295,556bps to -70,477.78% in 2022, then soared by 13,772,063bps to 67,242.86% in 2023, then plummeted by 9,601,933bps to -28,776.47% in 2024, then reached 213,980.00% in 2025.
- Its Operating Margin stands at 213,980.00% for Q3 2025, versus -28,776.47% for Q4 2024 and -562.70% for Q1 2024.